Bart Valkenburg B.ASc
Bart studied Biology & Medical Laboratory Research at the University of Applied Sciences Leiden with a focus on molecular biology. He did his final internship at the Department of Neurology at the Erasmus Medical Center in Rotterdam, focusing on the molecular characterization of EGFR mutations in their response to tyrosine kinase inhibitors. He continued working as a Technician at the Department of Internal Medicine where he performed a therapeutic screening for metastatic bone disease, before joining GenDx in January 2021. With his passion for research, Bart is highly motivated to contribute to the GenDx production and research for improving the quality of life of transplant patients.